March 17 (Reuters) - Biodelivery Sciences International Inc
* Biodelivery sciences provides corporate update and reports fourth quarter and full-year 2016 financial results
* Q4 loss per share $0.29
* Q4 revenue $3.9 million versus i/b/e/s view $3.9 million
* Q4 earnings per share view $-0.26 — Thomson Reuters I/B/E/S
* Biodelivery sciences international inc - intend to evaluate an array of belbuca-related business and commercial partnership opportunities
* Biodelivery sciences international inc - expect approval of belbuca in canada in first half of 2017
* Biodelivery sciences international inc- had cash and cash equivalents of approximately $32.0 million at december 31, 2016. Source text for Eikon: Further company coverage:
